Literature DB >> 10994808

SB-253514 and analogues: novel inhibitors of lipoprotein associated phospholipase A2 produced by Pseudomonas fluorescens DSM 11579. II. Physico-chemical properties and structure elucidation.

D J Busby1, R C Copley, J A Hueso, S A Readshaw, A Rivera.   

Abstract

A series of novel inhibitors of lipoprotein associated phospholipase A2 were isolated from the culture broths of Pseudomonas fluorescens strain DSM11579. The inhibitors fall into two structurally isomeric classes each of which comprise compounds incorporating glycosylated hydrocarbon chains. The structure elucidation for the major member of each structural class is reported. The crystal structure of a non-glycosylated analogue of the 5,5-series, produced through biotransformation, is also reported.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10994808

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  4 in total

Review 1.  A comprehensive review of glycosylated bacterial natural products.

Authors:  Sherif I Elshahawi; Khaled A Shaaban; Madan K Kharel; Jon S Thorson
Journal:  Chem Soc Rev       Date:  2015-11-07       Impact factor: 54.564

2.  Structure reassignment and synthesis of Jenamidines A1/A2, synthesis of (+)-NP25302, and formal synthesis of SB-311009 analogues.

Authors:  Jeremy R Duvall; Fanghui Wu; Barry B Snider
Journal:  J Org Chem       Date:  2006-10-27       Impact factor: 4.354

3.  Draft Genome Sequence of Lipopeptide-Producing Strain Pseudomonas fluorescens DSM 11579 and Comparative Genomics with Pseudomonas sp. Strain SH-C52, a Closely Related Lipopeptide-Producing Strain.

Authors:  Norbert Kirchner; Carolina Cano-Prieto; Menno van der Voort; Jos M Raaijmakers; Harald Gross
Journal:  Microbiol Resour Announc       Date:  2020-05-21

4.  Simple and efficient synthesis of bicyclic enol-carbamates: access to brabantamides and their analogues.

Authors:  Ondrej Záborský; Ľudmila Petrovičová; Jana Doháňošová; Ján Moncol; Róbert Fischer
Journal:  RSC Adv       Date:  2020-02-13       Impact factor: 4.036

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.